Loss of function in PCSK9, atherogenic lipoprotein concentrations, and calcific aortic valve stenosis

Back

ESC Premium Access

Loss of function in PCSK9, atherogenic lipoprotein concentrations, and calcific aortic valve stenosis

Session: Poster Session 5 - Implementing biomarkers for valvular heart disease

Topic: Aortic Valve Stenosis

Speaker: Doctor B. Arsenault (Quebec, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Benoit Arsenault

Centre de Recherche de lInstitut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec (Canada)

0 follower

9 more presentations in this session

Lipoprotein particle profiles compared with standard lipids in the association with sub-clinical aortic valve calcification in apparently healthy japanese men

Speaker: Mr T. Vu (Shiga, JP)

Access

Abstract

Slides

Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias

Speaker: Doctor E. Scheirlynck (Lugano, CH)

Access

Abstract

Slides

Advanced glycation end products accumulate in aortic valve tissue during calcification development in the absence of diabetes mellitus. A spectroscopic study.

Speaker: Doctor N. Anousakis-Vlachochristou (Athens, GR)

Access

Abstract

Slides

Hyperinsulinemia, hypertension and two clusters of biomarkers predict aortic stenosis in 10,144 Finnish men.

Speaker: Doctor M. Ojanen (Kuopio, FI)

Access

Abstract

Slides

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function and prognosis in elderly patients with valvular heart disease.

Speaker: Doctor B. Zhang (Beijing, CN)

Access

Abstract

Access the full session

Poster Session 5 - Implementing biomarkers for valvular heart disease

Speakers: Doctor B. Arsenault, Mr T. Vu, Doctor E. Scheirlynck, Doctor N. Anousakis-Vlachochristou, Doctor M. Ojanen...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources